In a mouse model of OVA-induced allergic asthma, STAT3 inhibition significantly reduced eosinophilia and neutrophilic as well as blood histamine levels [25••], suggesting mitochondrial STAT3 to be a promising target to prevent mast cell activation and its associated pathology. Here, STAT3 is linked to allergic asthma.